sur Pentixapharm Holding AG (isin : DE000A40AEG0)
Pentixapharm Holding AG Announces Board Changes
Pentixapharm Holding AG has implemented significant personnel changes within its governing bodies, effective March 1, 2025. The company's Management Board now mirrors that of its operational subsidiary, Pentixapharm AG, with leadership under Dr. Dirk Pleimes and Henner Kollenberg.
Dr. Andreas Eckert has transitioned back to the Supervisory Board, resuming his role as Chairman. His move follows a temporary position as the sole Management Board member after the departure of founder Dr. Hakim Bouterfa. Additionally, Dr. Harald Hasselmann's mandate on the Supervisory Board has been reactivated after a previous suspension due to conflicts of interest. Frank Perschmann, the interim Chairman, has exited the board with Eckert's return.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Pentixapharm Holding AG